There's More to Value Investing Than Low Prices

A version of this article previously appeared in the June 2020 issue of Morningstar ETFInvestor. Click here to download a complementary copy.

Value investors have been challenged over the past decade, with many value strategies lagging a broad market index. The average fund in the large-value Morningstar Category underperformed the Russell 1000 Index by 4.3 percentage points annually over the trailing 10 years through May 2020.

Despite the recent performance drought, the long-term track record of value-oriented strategies and their underlying economic logic provide compelling reasons to stay the course. Stock prices and expected returns are linked, with lower prices translating into higher discount rates and higher expected returns. All else equal, lower prices should allow an investor’s dollar to go further.

But value investing has always been and likely always will be difficult because practitioners are betting against the market. If the intrinsic value of a business is the present value of its future cash flows, they’re wagering that the market has underestimated the magnitude of those cash flows or that it has excessively discounted them. In either case, value investors claim that the underlying business is worth more than the market’s price.

Betting that the market has mispriced a stock is a risky proposition. Forecasting future cash flows and discount rates is wrought with uncertainty because the future is unknowable. As we rang in the new year, few would have guessed that a virus outbreak in China would rapidly spread around the world and slow the global economy to a crawl, spurning the near-term earnings of many businesses.

Unexpected circumstances like these throw a wrench into the cash flow generating machinery of businesses, making it difficult if not impossible to forecast what they will be worth in the future. This is a task that has proved difficult for some of the greatest investors to pull off even once in a while, let alone consistently. Their experiences impart some important lessons.

Even the Oracle Gets It Wrong

One of Warren Buffett’s early business deals illustrates the perils that come from betting against the market. In 1975, he acquired New England textile manufacturer Waumbec Mills at a rock-bottom price. Waumbec’s operations also complemented Berkshire Hathaway’s existing textile production, offering the potential for efficiency improvements. On the surface, there wasn’t much to dislike about the deal.

But Waumbec Mills was cheap for a reason. Beneath the attractive sticker price sat a beleaguered company in a deteriorating industry. Prior to the acquisition, Waumbec had operated at a loss, with the factory functioning at about half its capacity. And while it was difficult to see at the time, U.S. textile manufacturing would be all but extinct within the next decade.

An extraordinary effort by Buffett and his team helped Waumbec become profitable, though the result didn’t quite live up to his initial expectations. While the investment netted a small gain, the lost opportunities proved costly: The time and money spent attempting to turn Waumbec Mills around couldn’t be deployed on more-lucrative deals or acquisitions.

In his own words, Buffett acknowledged that “Both our operating and investment experience cause us to conclude that ‘turnarounds’ seldom turn, and that the same energies and talent are much better employed in a good business purchased at a fair price than in a poor business purchased at a bargain price.”[1]

More Than Low Prices

Buffett’s proselytism—shifting his preference to good businesses purchased at fair prices—is more than a folksy one-liner. Intuitively, good businesses with strong profits should have the ability to reinvest in their operations, further growing future profits and cash flows.

There is strong empirical evidence to support the argument for investing in high-quality, profitable businesses. In his paper “The Other Side of Value,” Robert Novy-Marx demonstrated that highly profitable companies outperform their less-profitable counterparts.[2] Current profitability has proved to be a decent predictor of future profitability.

Yet more-profitable companies tend to trade at higher valuations than less-profitable companies. That relationship is apparent in fund-level data. Exhibit 1 plots the price/book ratio of open-end mutual funds and ETFs in the large-value category against their profitability (measured by return on invested capital).

Paying up for strong profitability doesn’t harm performance because valuations and profitability provide different pieces of information about a stock’s future performance. Low valuations could reflect high discount rates or expectations of low future cash flows. Firms with high profitability tend to be worth more because they should generate higher future cash flows. Valuations alone don’t say much about future cash flows, while profitability alone ignores discount rates. Combining the two helps better identify which stocks will likely have strong performance in the future.

The matrix in Exhibit 2 was compiled using data from the Ken French data library. It sorts the historical performance of U.S. stocks by their price/book ratio and operating profitability. At a high level, it demonstrates that stocks trading at lower valuations and higher profitability tend to outperform those with the opposite characteristics.

Across all five valuation quintiles, stocks in the lowest profitability cohort underperformed those in cohort 2, often by several percentage points per year. In the context of a value strategy, a strong focus on profitability isn’t necessarily required to improve performance. Avoiding the least-profitable names can dramatically improve performance over a value strategy that does not consider a stock’s profitability.

Value and Profitability Work Better Together

Value investing works on its own, without considering profitability. Stocks with low multiples tend to have high discount rates and expected returns. But low multiples alone don’t account for a firm’s future cash flows, so they are at best a crude indicator of future performance. Incorporating profitability provides additional information about a firm’s expected cash flows. Combining valuations and profitability better isolates differences in discount rates across stocks, which should provide a better signal about which stocks should perform well in the future.

Exchange-traded funds that explicitly tilt toward profitable stocks trading at lower valuations are few and far between. While not a value fund, Avantis U.S. Equity ETF (AVUS) tries to simultaneously emphasize stocks trading at lower valuations and higher profitability. As of April 2020, AVUS’ price/book ratio was below that of the Russell 1000 Index, while its return on invested capital was similar, as Exhibit 3 shows. IShares MSCI USA Multifactor ETF (LRGF) also tilts toward stocks trading at lower valuations and higher profitability while also emphasizing names with strong momentum and smaller market capitalizations.

Funds that track Standard and Poor’s value indexes, like iShares S&P Small-Cap 600 Value ETF (IJS) or iShares S&P 500 Value ETF (IVE), might also be worth considering. These indexes require new constituents to be profitable to qualify for inclusion. These funds have similar valuations to the Russell 1000 and Russell 2000 Value indexes, respectively, but have noticeably higher profitability.

[1] Buffett, W. 1979. “Berkshire Hathaway Shareholder Letter.”

[2] Novy-Marx, R. 2010. “The Other Side of Value.” NBER Working Paper.

Disclosure: Morningstar, Inc. licenses indexes to financial institutions as the tracking indexes for investable products, such as exchange-traded funds, sponsored by the financial institution. The license fee for such use is paid by the sponsoring financial institution based mainly on the total assets of the investable product. Please click here for a list of investable products that track or have tracked a Morningstar index. Neither Morningstar, Inc. nor its investment management division markets, sells, or makes any representations regarding the advisability of investing in any investable product that tracks a Morningstar index.